Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, has successfully completed its vaccine prototype.
read more
DefiniGEN has identified iPSC-derived intestinal organoids that could be used to help structure in vitro studies of the biology of SARS-CoV2 infection across cohorts of multiple patients.
read more
Hetero has entered into a licensing agreement with Gilead Sciences for the manufacturing and distribution of Remdesivir for the treatment of Covid-19.
read more
Exyte and Univercells Technologies are announcing a global partnership for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.
read more
Sabin announced BARDA has exercised the first two options, valued at $20 million advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.
read more
ApiJect Systems America has been awarded an HHS-DOD Title 3, DPA contract to accelerate the building of a new U.S.-based, high-speed, population-scale emergency drug injection capability with prefilled syringes from its subsidiary RAPID USA Inc.
read more
Parexel has unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks.
read more
Fluxergy is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer diagnostic testing system in response to the COVID-19 pandemic.
read more
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Parexel unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks as well as cGMP inspection and CMC review processes to ensure that manufacturers can safely and confidently continue ...
read more
Fresenius Medical Care North America's Renal Therapies Group is preparing its first shipment of multiBic dialysate solutions for use in continuous renal replacement therapy.
read more
Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
read more
During COVID-19, FDA will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections.
read more
In response to scammers on the internet selling unproven medical products, the FDA has taken a number of steps to find and stop those selling unapproved products that fraudulently claim to mitigate, prevent, treat, diagnose or cure COVID-19.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more